Nucleolar localization of cirhin, the protein mutated in North American Indian childhood cirrhosis

doi:10.1016/j.yexcr.2005.08.012

Experimental Cell Research

Volume 311, Issue 2, 10 December 2005, Pages 218-228

https://doi.org/10.1016/j.yexcr.2005.08.012 Get rights and content

Abstract

Cirhin (NP_116219), the product of the CIRH1A gene is mutated in North American Indian childhood cirrhosis (NAIC/CIRH1A, OMIM 604901), a severe autosomal recessive intrahepatic cholestasis. It is a 686-amino-acid WD40-repeat containing protein of unknown function that is predicted to contain multiple targeting signals, including an N-terminal mitochondrial targeting signal, a C-terminal monopartite nuclear localization signal (NLS) and a bipartite nuclear localization signal (BNLS). We performed the direct determination of subcellular localization of cirhin as a crucial first step in unraveling its biological function. Using EGFP and His-tagged cirhin fusion proteins expressed in HeLa and HepG2, cells we show that cirhin is a nucleolar protein and that the R565W mutation, for which all NAIC patients are homozygous, has no effect on subcellular localization. Cirhin has an active C-terminal monopartite nuclear localization signal (NLS) and a unique nucleolar localization signal (NrLS) between residues 315 and 432. The nucleolus is not known to be important specifically for intrahepatic cholestasis. These observations provide a new dimension in the study of hereditary cholestasis.

Introduction

North American Indian childhood cirrhosis (NAIC/CIRH1A, OMIM 604901) is a severe nonsyndromic autosomal recessive intrahepatic cholestasis presenting with transient neonatal jaundice and progressing to periportal fibrosis and cirrhosis in childhood and adolescence. Liver transplantation is the only known effective therapy [1]. The NAIC/CIRH1A locus was mapped to chromosome 16q22 [2]. All NAIC patients tested to date are homozygous for a mutation in GenBank cDNA sequence NM_032830 (c.1741C→T) that changes a conserved arginine at position 565 to tryptophan (R565W) in cirhin, the product of the NAIC/CIRH1A locus. This mutation is predicted to change the secondary structure of the protein [3].

Cirhin (NP_116219) is a 686-amino-acid protein of unknown function. Its calculated MW is 76 kDa and is predicted to have a pI of 9.3. Bioinformatic analyses predict that cirhin is a WD40-repeat containing protein with multiple targeting signals, including an N-terminal mitochondrial targeting signal, a C-terminal monopartite nuclear localization signal (NLS, residues 677–686) and a bipartite nuclear localization signal (BNLS, residues 328–344) (Fig. 1A). Cirhin is conserved in vertebrates, including mouse, rat, cow, zebrafish, salmon [3] and Xenopus laevis (gi:27769180). The mouse ortholog TEX292 (NP_035704) has 88% amino acid identity to human cirhin. Tex292 is expressed predominantly in testis and liver, and expression increased during neonatal testis development [4], [5]. In-situ hybridization in mouse embryos at 11.5 days p.c. revealed high and predominant expression in liver, with lower expression in somites, brain and craniofacial structures. Expression significantly decreases in day 12.5 embryos and in the newborn [3].

Since the function of cirhin is unknown and given that bioinformatic analyses predict different potential subcellular localizations, direct determination of subcellular localization of cirhin is a crucial first step in unraveling its biological function.

Using EGFP and His-tagged cirhin fusion proteins expressed in HeLa cells, we show that cirhin is a nucleolar protein containing an active C-terminal monopartite nuclear localization signal (NLS) (residues 677–686) and a unique nucleolar localization signal (NrLS) between amino acids 315 and 432.

Section snippets

Domain prediction methods and web source

Predotar http://www.inra.fr/predotar/
MITOPROT http://www.mips.biochem.mpg.de/cgi-bin/proj/medgen/mitofilter
SIB http://hits.isb-sib.ch/cgi-bin/PFSCAN
PSORT http://psort.nibb.ac.jp/cgi-bin/

Cirhin cDNA and plasmids

Mammalian Gene Collection (MGC, http://mgc.nci.nih.gov/) clone 16757, Accession # BC009348 (American Type Culture Collection, Manassas, VA), was used as the full-length normal human Cirhin cDNA template. pcDNA3.1- (Invitrogen Canada, Burlington, Ont) was used to generate N-terminal and C-terminal 6× His-tagged

Normal and mutant cirhin are located in the nucleolus

Bioinformatic predictions yielded several potential subcellular locations for cirhin (Fig. 1A), thus direct experimental evidence was needed to establish subcellular localization. Transient transfection of HeLa cells with full-length cirhin tagged at the C-terminal with EGFP (Cirhin-EGFP) shows the presence of the fusion protein in nucleoli (Fig. 2A, panels 1a–e). In contrast, the vector control (pEGFP-N1) showed homogeneous distribution of EGFP throughout the cytoplasm and nuclei (data not

Discussion

Using transient and stable transfections with EGFP and His-tagged full-length constructs, we determined that cirhin is a novel nucleolar protein. Several proteomic studies on the composition of HeLa nucleoli were published [9], [10], [11]. While cirhin was not reported in the first publication, during our study, the second group identified a hypothetical 59.6-kDa peptide (Q9BWK6), but it was unrecognized as the C-terminal fragment of cirhin. The major activity of the nucleolus is to coordinate

Acknowledgment

These studies are supported by grant #MOP-38050 from the Canadian Institutes of Health Research.

References (48)

C. Betard et al.
Localization of a recessive gene for North American Indian childhood cirrhosis to chromosome region 16q22 and identification of a shared haplotype
Am. J. Hum. Genet.
(2000)
P. Chagnon et al.
A missense mutation (R565W) in cirhin (FLJ14728) in North American Indian Childhood Cirrhosis
Am. J. Hum. Genet.
(2002)
B.C. Valdez et al.
Identification of the nuclear and nucleolar localization signals of the protein p120. Interaction with translocation protein B23
J. Biol. Chem.
(1994)
C.H. Dang et al.
Nuclear and nucleolar targeting sequences of c-erbA, c-myb, N-myc, p53, HSP70, and HIV tat proteins
J. Biol. Chem.
(1989)
J.S. Andersen et al.
Directed proteomic analysis of the human nucleolus
Curr. Biol.
(2002)
M.R. Hodel et al.
Dissection of a nuclear localization signal
J. Biol. Chem.
(2001)
Y. Miyazaki et al.
The post-transcriptional regulator Rev of HIV: implications for its interaction with the nucleolar protein B23
Biochimie
(1996)
S. Thebault et al.
Sequence requirement for the nucleolar localization of human I-mfa domain-containing protein (HIC p40)
Eur. J. Cell Biol.
(2000)
M. Antoine et al.
Fibroblast growth factor 3, a protein with dual subcellular localization is targeted to the nucleus and nucleolus by the concerted action of two nuclear localization signals and a nucleolar retention signal
J. Biol. Chem.
(1997)
N. Ueki et al.
NOLP: identification of a novel human nucleolar protein and determination of sequence requirements for its nucleolar localization
Biochem. Biophys. Res. Commun.
(1998)

P. Sudbeck et al.

Two independent nuclear localization signals are present in the DNA-binding high-mobility group domains of SRY and SOX9

J. Biol. Chem.

(1997)

M.R. Fontes et al.

Structural basis of recognition of monopartite and bipartite nuclear localization sequences by mammalian importin-alpha

J. Mol. Biol.

(2000)

J.K. Ospina et al.

Proteomics: the nucleolus weighs in

Curr. Biol.

(2002)

M.O. Olson et al.

Conventional and nonconventional roles of the nucleolus

Int. Rev. Cytol.

(2002)

E. Drouin et al.

A North American Indian cirrhosis in children: a review of 30 cases

J. Pediatr. Gastroenterol. Nutr.

(2000)

L.A. Lopez-Fernandez et al.

Characterization of genes expressed early in mouse spermatogenesis, isolated from a subtractive cDNA library

Mamm. Genome

(1996)

T. Nagase et al.

Prediction of the coding sequences of unidentified human genes XXII. The complete sequences of 50 new cDNA clones which code for large proteins

DNA Res.

(2001)

M.O.J. Olson et al.

The moving parts of the nucleolus

Histochem. Cell Biol.

(2005)

A. Scherl et al.

Functional proteomic analysis of human nucleolus

Mol. Biol. Cell

(2002)

A.K. Leung et al.

Bioinformatic analysis of the nucleolus

Biochem. J.

(2003)

J.S. Andersen et al.

Nucleolar proteome dynamics

Nature

(2005)

B.B. Quimby et al.

Nuclear transport mechanisms

Cell. Mol. Life Sci.

(2001)

M. Cokol et al.

Finding nuclear localization signals

EMBO Rep.

(2000)

C. Wychowski et al.

The intranuclear location of simian virus 40 polypeptides VP2 and VP3 depends on a specific amino acid sequence

J. Virol.

(1987)

Cited by (22)

Antinuclear antibodies in individuals with COVID-19 reflect underlying disease: Identification of new autoantibodies in systemic sclerosis (CDK9) and malignancy (RNF20, RCC1, TRIP13)
2023, Autoimmunity Reviews
A high prevalence of antinuclear antibodies (ANA) in COVID-19 has been insinuated, but the nature of the target antigens is poorly understood. We studied ANA by indirect immunofluorescence in 229 individuals with COVID-19. The target antigens of high titer ANA (≥1:320) were determined by immunoprecipitation (IP) combined with liquid-chromatography-mass spectrometry (MS). High titer ANA (≥1:320) were found in 14 (6%) of the individuals with COVID-19. Of the 14 COVID-19 cases with high titer ANA, 6 had an underlying autoimmune disease and 5 a malignancy. IP-MS revealed known target antigens associated with autoimmune disease as well as novel autoantigens, including CDK9 (in systemic sclerosis) and RNF20, RCC1 and TRIP13 (in malignancy). The novel autoantigens were confirmed by IP-Western blotting. In conclusion, in depth analysis of the targets of high titer ANA revealed novel autoantigens in systemic sclerosis and in malignant disease.
Developmental and Inherited Liver Disease
2023, MacSween's Pathology of the Liver, Eighth Edition
A section on the approach to diagnostic histological interpretation is the overture to this chapter on inherited and developmental disorders. This initial section is split chronologically into the early neonatal and infantile period and later childhood and adulthood, with the intention of reflecting clinical practice as closely and succinctly as possible. Disorders of the biliary tree, bile formation and secretion and hepatocyte metabolism are the core of this chapter, a merger of Chapters 3 and 4 of previous editions. Considerations on the pathogenetic and/or clinical overlap among developmental, genetic and metabolic disorders were the rationale behind this change. The complexity of hepatocyte metabolism is reflected into the myriad of related pathological conditions. Two short new paragraphs on disorders of manganese metabolism and DNA repair and nuclear envelope have been added. Recent technological advances, particularly in genomics in the last 5 years, have resulted in a plethora of new entities and changes in terminology, challenging the authors to balance detail and application to clinical practice. Tables and figures from the previous edition have been largely kept due to their quality and contemporary relevance, and updated where necessary. Liver involvement in immunodeficiency and miscellaneous disorders precede the final section on anatomical anomalies. Vascular anomalies are now included in the chapters on vascular disorders.
Identification and genomic analysis of pedigrees with exceptional longevity identifies candidate rare variants
2020, Neurobiology of Disease
Citation Excerpt :
UTP4 encodes a WD40-repeat-containing protein that is localized to the nucleolus. Variation in UTP4 is significantly associated with North American Indian childhood cirrhosis (Freed and Baserga, 2010; Yu et al., 2005). Individuals in one cousin pair carry the missense mutation rs61753103 in the gene NUP88.
Longevity as a phenotype entails living longer than average and typically includes living without chronic age-related diseases. Recently, several common genetic components to longevity have been identified. This study aims to identify additional genetic variants associated with longevity using unique and powerful analyses of pedigrees with a statistical excess of healthy elderly individuals identified in the Utah Population Database (UPDB).
From an existing biorepository of Utah pedigrees, six independent cousin pairs were selected from four extended pedigrees that exhibited an excess of healthy elderly individuals; whole exome sequencing (WES) was performed on two elderly individuals from each pedigree who were either first cousins or first cousins once removed. Rare (<.01 population frequency) variants shared by at least one elderly cousin pair in a region likely to be identical by descent were identified as candidates. Ingenuity Variant Analysis was used to prioritize putative causal variants based on quality control, frequency, and gain or loss of function. The variant frequency was compared in healthy cohorts and in an Alzheimer's disease cohort. Remaining variants were filtered based on their presence in genes reported to have an effect on the aging process, aging of cells, or the longevity process. Validation of these candidate variants included tests of segregation on other elderly relatives.
Fifteen rare candidate genetic variants spanning 17 genes shared within cousins were identified as having passed prioritization criteria. Of those variants, six were present in genes that are known or predicted to affect the aging process: rs78408340 (PAM), rs112892337 (ZFAT), rs61737629 (ESPL1), rs141903485 (CEBPE), rs144369314 (UTP4), and rs61753103 (NUP88 and RABEP1). ESPL1 rs61737629 and CEBPE rs141903485 show additional evidence of segregation with longevity in expanded pedigree analyses (p-values = .001 and .0001, respectively).
This unique pedigree analysis efficiently identified several novel rare candidate variants that may affect the aging process and added support to seven genes that likely contribute to longevity. Further analyses showed evidence for segregation for two rare variants, ESPL1 rs61737629 and CEBPE rs141903485, in the original longevity pedigrees in which they were initially observed. These candidate genes and variants warrant further investigation.
Developmental and Inherited Liver Disease
2018, MacSween's Pathology of the Liver
A new section on the approach to diagnostic histological interpretation, is the overture to this chapter on inherited and developmental disorders. This initial section is split chronologically into the early neonatal and infantile period and later childhood and adulthood; with the intention of reflecting clinical practice as closely and succinctly as possible. Disorders of the biliary tree, bile formation and secretion, and hepatocyte metabolism are the core of this chapter, a merger of chapters 3 and 4 of the previous edition. Considerations on the pathogenetic and/or clinical overlap between developmental, genetic and metabolic disorders were the rationale behind this change. The complexity of hepatocyte metabolism is reflected into the miriad of related pathological conditions. Recent technological advances, particularly in genomics in the last five years, have resulted in a plethora of new entities and changes in terminology, challenging the authors to balance detail and application to clinical practice. Tables and figures from previous editions have been largely kept due to their quality and contemporary relevance, whilst new ones have been added to accommodate new advances (e.g. classification of mitochondrial disorders), a compromise to bridge between the two editions for the accustomed reader. Liver involvement in immunodeficiency and miscellaneous disorders precede the final section on anatomical anomalies. Vascular anomalies are now included in the chapters on vascular disorders.
Growth arrest in the ribosomopathy, bowen-conradi syndrome, is due to dramatically reduced cell proliferation and a defect in mitotic progression
2015, Biochimica et Biophysica Acta - Molecular Basis of Disease
Citation Excerpt :
We previously described G2/M accumulation and slow proliferation rates in BCS patient lymphoblasts [4]. However, accumulation at G2/M and/or mitotic spindle defects have also been observed in other ribosome biogenesis disorders, including Shwachman–Diamond syndrome [35], Treacher Collins syndrome [34], X-linked dyskeratosis congenita [33,39], and North American Indian childhood cirrhosis [36]. The factors responsible for these disorders frequently re-localize to the mitotic spindle or the chromosome periphery during mitosis, similar to EMG1 (Fig. 6H–M).
Bowen–Conradi syndrome (BCS) is a ribosomopathy characterized by severe developmental delay and growth failure that typically leads to death by one year of age. It is caused by a c.257A>G, p.D86G substitution in the ribosomal biogenesis protein, Essential for Mitotic Growth 1 (EMG1). We generated a knock-in of the D86G substitution in mice to characterize the effects of EMG1 deficiency, particularly in the brain, where EMG1 expression is high. Embryos homozygous for the mutation in Emg1 were small for gestational age with neural tube defects, and died between embryonic days 8.5 and 12.5. These embryos exhibited dramatically reduced cell proliferation, which we also detected in autopsy brain tissue and bone marrow of BCS patients, consistent with a requirement for high levels of EMG1 in tissues with rapid cell proliferation. In fibroblasts derived from the BCS mouse embryos, we detected a high proportion of binucleated cells, indicating that a mitotic defect underlies the growth arrest in BCS. These studies add to growing evidence of a link between ribosome biogenesis, mitotic progression, and brain development that is currently unexplored.
Human diseases of the SSU processome
2014, Biochimica et Biophysica Acta - Molecular Basis of Disease
Citation Excerpt :
Using Y2H analysis, hUTP4/Cirhin was found to interact with Cirip, a protein required for transcription of the HIV-1 LTR enhancer element. However, hUTP4/Cirhin is nucleolar [19,21], while Cirip is nuclear [15] indicating that an interaction between these two proteins is not likely required for the role of hUTP4/Cirhin in ribosome biogenesis. We are still left to wonder, is nucleolar dysfunction the root cause of NAIC?
Ribosomes are the cellular machines responsible for protein synthesis. Ribosome biogenesis, the production of ribosomes, is a complex process involving pre-ribosomal RNA (rRNA) cleavages and modifications as well as ribosomal protein assembly around the rRNAs to create the functional ribosome. The small subunit (SSU) processome is a large ribonucleoprotein (RNP) in eukaryotes required for the assembly of the SSU of the ribosome as well as for the maturation of the 18S rRNA. Despite the fundamental nature of the SSU processome to the survival of any eukaryotic cell, mutations in SSU processome components have been implicated in human diseases. Three SSU processome components and their related human diseases will be explored in this review: hUTP4/Cirhin, implicated in North American Indian childhood cirrhosis (NAIC); UTP14, implicated in infertility, ovarian cancer, and scleroderma; and EMG1, implicated in Bowen–Conradi syndrome (BCS). Diseases with suggestive, though inconclusive, evidence for the involvement of the SSU processome in their pathogenesis are also discussed, including a novel putative ribosomopathy. This article is part of a Special Issue entitled: Role of the Nucleolus in Human Disease.

View all citing articles on Scopus

View full text

Research ArticleNucleolar localization of cirhin, the protein mutated in North American Indian childhood cirrhosis

Abstract

Introduction

Section snippets

Domain prediction methods and web source

Cirhin cDNA and plasmids

Normal and mutant cirhin are located in the nucleolus

Discussion

Acknowledgment

Am. J. Hum. Genet.

Am. J. Hum. Genet.

J. Biol. Chem.

J. Biol. Chem.

Curr. Biol.

J. Biol. Chem.

Biochimie

Eur. J. Cell Biol.

J. Biol. Chem.

Biochem. Biophys. Res. Commun.

J. Biol. Chem.

J. Mol. Biol.

Curr. Biol.

Int. Rev. Cytol.

A North American Indian cirrhosis in children: a review of 30 cases

J. Pediatr. Gastroenterol. Nutr.

Characterization of genes expressed early in mouse spermatogenesis, isolated from a subtractive cDNA library

Mamm. Genome

Prediction of the coding sequences of unidentified human genes XXII. The complete sequences of 50 new cDNA clones which code for large proteins

DNA Res.

The moving parts of the nucleolus

Histochem. Cell Biol.

Functional proteomic analysis of human nucleolus

Mol. Biol. Cell

Bioinformatic analysis of the nucleolus

Biochem. J.

Nucleolar proteome dynamics

Nature

Nuclear transport mechanisms

Cell. Mol. Life Sci.

Finding nuclear localization signals

EMBO Rep.

The intranuclear location of simian virus 40 polypeptides VP2 and VP3 depends on a specific amino acid sequence

J. Virol.

Research Article
Nucleolar localization of cirhin, the protein mutated in North American Indian childhood cirrhosis